
TB-500
Thymosin Beta-4 Fragment
Actin-sequestering peptide fragment. Lyophilised, sealed at 18 °C. Isolated for its structural simplicity and synthetic accessibility, TB-500 is produced as a lyophilised solid and sealed under inert atmosphere.
Every batch moves through the full Six-Step protocol — solid-phase Fmoc synthesis, TFA cleavage, reverse-phase HPLC purification, and ESI-TOF mass-spec confirmation. The lot shipped carries ≥ 99.11% HPLC-MS purity with residual solvent and endotoxin assays signed by an independent laboratory.
Lyophilised vials are stable at −20 °C in their sealed amber container. In bacteriostatic water, HPLC-verified purity holds for approximately four weeks under refrigeration; single-thaw only.
- Sequence
- LKKTETQ
- Molecular weight
- 889.04 g/mol
- Purity (HPLC-MS)
- 99.11%
- Dose · fill
- 10 mg
- Lot number
- A-4420
- CoA date
- 2026-03-17
- Storage
- −20 °C · thaw once
- Shipping
- Cold-chain, 1-day overnight

Fig. — Amber borosilicate vial, argon-flushed, 10 mg fill.
- Lot
- A-4420
- Dose
- 10 mg
- In stock
- 138 vials
- Dispatch
- Within 24h
- Storage
- −20 °C · thaw once
Ships in 1–2 business days


